The study discusses the Lean Mass Hypersponders phenotype characterized by high LDL cholesterol, high HDL cholesterol, and low triglycerides. This phenotype, identified in 2017, is rare in the general population and is more prevalent in individuals who are athletic, follow a low-carb diet, and are lean. The study highlights the importance of further research to understand this unique metabolic profile.
Today, Paul has Dave Feldman on the podcast to discuss, in depth, a recent study that he conducted about LDL and cardiovascular risk and what this may mean for the future of medicine.
*Produced by Mountain Valley Media
00:03:30 The genesis of Dave’s most recent study
00:07:00 is FH a phenotype or genotype polygenetic vs monogenetic
00:22:30 Dave’s overall perspective while conducting studies
0:24:00 Diving into Dave Feldman’s most recent study: Does APOE-B cause atherosclerosis
00:42:30 How the medical community has received this study
00:46:30 Do credentials matter?
00:58:30 Thoughts on Statins
01:04:45 What alters lipid levels
01:13:30 Connect with Dave
References:
Twitter: @realdavefeldman
Instagram: @realdavefeldman
Youtube: youtube.com/@realdavefeldman
https://citizensciencefoundation.org/